# 바이오스페이스 일일 뉴스 리포트 - 2025년 12월 11일


## 주요 헤드라인

1. **Weight Loss Waves, Pazdur’s Exit and FDA Instability, New Neuro Breakthroughs (#뉴스)**
   - Article content not available
   <https://www.biospace.com/drug-development/weight-loss-waves-pazdurs-exit-and-fda-instability-new-neuro-breakthroughs>

2. **Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/pfizer-is-not-a-done-dealmaker-after-metsera-buy-with-6b-more-to-spend>

3. **Japanese Pharmas Looking Beyond Borders for M&A to US, EU (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/japanese-pharmas-looking-beyond-borders-for-m-a-to-us-eu>

4. **Regeneron Climbs Back After a Year of Regulatory, Manufacturing Misery (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/regeneron-climbs-back-after-a-year-of-regulatory-manufacturing-misery>

5. **Regeneron Climbs Back After a Year of Regulatory, Manufacturing Misery (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/regeneron-climbs-back-after-a-year-of-regulatory-manufacturing-misery>

6. **With Chinese Assets in Hand, Pharma Is Wondering What Else Can Be Learned (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/with-chinese-assets-in-hand-pharma-is-wondering-what-else-can-be-learned>

7. **With Chinese Assets in Hand, Pharma Is Wondering What Else Can Be Learned (#뉴스)**
   - Article content not available
   <https://www.biospace.com/business/with-chinese-assets-in-hand-pharma-is-wondering-what-else-can-be-learned>


---
*2025년 12월 11일 바이오스페이스 뉴스 피드에서 생성된 리포트*